Log In
Print
BCIQ
Print
Print this Print this
 

PF-06687859, RG3039

  Manage Alerts
Collapse Summary General Information
Company Repligen Corp.
DescriptionSmall molecule inhibitor of decapping enzyme scavenger (DCPS)
Molecular Target Decapping enzyme scavenger (DCPS)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationSpinal muscular atrophy (SMA)
Indication DetailsTreat spinal muscular atrophy (SMA)
Regulatory Designation

U.S. - Fast Track (Treat spinal muscular atrophy (SMA));
U.S. - Orphan Drug (Treat spinal muscular atrophy (SMA));
EU - Orphan Drug (Treat spinal muscular atrophy (SMA))

Partner

Pfizer Inc.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today